Oculis Holding AG (OCSAW) Stock Price & Analysis
Oculis Holding AG (OCSAW) closed at USD 2.6 on Thursday, October 15, 2026, up 4.42% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 2.49; the Oct 15, 2026 session ranged USD 2.27–3.06 on volume of 45,796 shares. Market capitalization is —, with a 52-week range of USD 2.27–3.06 (NGM). Source: Nexqual, retrieved October 16, 2026 at 05:11 UTC.
Also available as compact Markdown for AI agents: nexqual.com/OCSAW.md
Key facts (OCSAW)
- Analysts: None.
Analysts (OCSAW)
Consensus None.
Key Statistics (as of October 16, 2026 at 05:11 UTC)
| Price | USD 2.6 |
|---|---|
| Change | ▲ 4.42% (up) |
| Previous Close | USD 2.49 |
| Open | USD 9.91 |
| Day Range | USD 2.27 – 3.06 |
| 52-Week Range | USD 2.27 – 3.06 |
| Volume | 45,796 shares |
| Market Cap | — |
| Exchange | NGM |
Analyst Ratings (OCSAW)
Wall Street analysts rate OCSAW "None", per Nexqual as of October 16, 2026 at 05:11 UTC.
| Consensus Rating | None |
|---|
Earnings (OCSAW)
| Revenue Estimate | $157,590 |
|---|
Source: Nexqual, October 16, 2026 at 05:11 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| OCS | Oculis Holding AG | USD 7.4 | ▼ 2.89% |
| ALVOW | Alvotech Warrant | USD 0.45 | ▲ 0% |
| NAMSW | NewAmsterdam Pharma Company N.V | USD 10.95 | ▲ 0% |
| NRSNW | NEUROSENSE THERAPEUTICS LTD C/W | USD 0.01 | ▲ 1.94% |
| ENGNW | enGene Holdings Inc. Warrants | USD 0.17 | ▲ 5.07% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 16, 2026 at 05:11 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt